Systemic Sclerosis

As per available reports about 193 journals, 68 Conferences, 16 workshops are presently dedicated exclusively to systemic sclerosis and about 22479 articles are being published on the current trends in systematics. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to systemic sclerosis are being carried out. As stated by Mayo Clinic, Systemic sclerosis is an autoimmune or connective tissue disease that is characterized by thickening of the skin caused by accumulation of collagen, and by injuries to the smallest arteries.

The Journal of Clinical & Cellular Immunology is an academic journal – hosted by OMICS International – a pioneer in open access publishing. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Clinical & Cellular Immunology provides a unique platform to researchers and scientist to explore the advanced and latest research in systematic sclerosis, thus bridging the gap between researchers and young scientists.

OMICS International, a pioneer in organizing international conferences and with the great success of previous International Immunology conferences- International Symposiums, OMICS Group is proud to organize the 3rd International Conference and Exhibition on Clinical & Cellular Immunology (Immunology Summit-2014) during September 29th - October 01st, 2014 at Baltimore, USA with a theme “From basic immune understanding to clinical breakthroughs”.

OMICS Group hosts over 400 leading-edge peer reviewed Open Access Journals and organize over 300 International Conferences annually all over the world. OMICS International journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities that ensure a rapid, quality and quick review process. OMICS Group signed an agreement with more than 500 International Societies to make healthcare information Open Access.